MELD 3.0: Exploring and expanding its utility beyond transplantation
Hepatology Forum · 2026 · 7 (3) · 241-248
DOI: 10.14744/hf.2026.50793 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hepatology Forum, 2026. Verfasst von Pavan Kumar Reddy Kalluru und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, West Anaheim Medical Center, Anaheim, California, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
he model for end-stage liver disease (MELD) score has evolved into a cornerstone of liver transplantation prioritization. With the recent development of MELD 3.0, which incorporates serum albumin and sex-adjusted variables, its predictive accuracy and applicability have expanded significantly. This review examines the potential clinical applications of MELD 3.0 beyond transplant selection, highlighting its utility as a broader prognostic tool across various hepatic and systemic conditions. Data from multiple domains suggest that MELD 3.0 provides meaningful clinical insight. In orthotopic heart transplantation, MELD 3.0 has demonstrated superior predictive power for short-term mortality and postoperative intensive care unit resource utilization. In acute variceal hemorrhage, it has maintained good discriminatory ability, although calibration challenges limit its use as a standalone tool. Among patients with hepatocellular carcinoma and renal insufficiency, MELD 3.0 has shown moderate predictive value for survival but has been outperformed by albumin-bilirubin-based models. In transjugular intrahepatic portosystemic shunt procedures, MELD 3.0 has effectively stratified pre- and postprocedural risk, enhancing dynamic patient monitoring and decisions regarding transplant timing. For alcohol-associated hepatitis, MELD 3.0 has surpassed older models in predicting mortality and the need for renal replacement therapy, particularly in women and malnourished patients. In oncology, MELD 3.0 has contributed to mortality risk assessment in hepatic visceral crisis when combined with inflammatory markers. However, its performance has been less robust in hepatic hydrothorax, where mortality has occurred at lower MELD scores, and in spontaneous bacterial peritonitis, where it has performed comparably to other MELD variants. Collectively, these findings underscore the growing relevance of MELD 3.0 as a generalizable risk stratification tool across acute and chronic liver-related conditions. Although further prospective validation is warranted, its incorporation into routine hepatology and multidisciplinary care pathways may enhance prognostic precision and inform therapeutic decision-making beyond transplantation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, West Anaheim Medical Center, Anaheim, California, USA.
- Department of Gastroenterology, West Anaheim Medical Center, Anaheim, California, USA.
- Department of General Medicine, Sri Venkateswara Medical College, Tirupati, India.
- Department of Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, Florida, USA.
- Department of General Surgery, Vinayaka Missions Medical College and Hospitals, Puducherry, India.
- Department of General Medicine, Apollo Institute of Medical Sciences and Research, Chittoor, India.
Zitieren
APA
Kalluru, P. K. R., Buhulaigah, H. E., Allikesam, K. K., Kuchi, D., Muqtadir, A., Onteddu, N., Cherukuri, A., Allagadda, T., Kamakkagari, M., & Rajali, H. (2026). MELD 3.0: Exploring and expanding its utility beyond transplantation. Hepatology Forum, 7(3), 241-248. https://doi.org/10.14744/hf.2026.50793
Vancouver
Kalluru PKR, Buhulaigah HE, Allikesam KK, Kuchi D, Muqtadir A, Onteddu N, et al. MELD 3.0: Exploring and expanding its utility beyond transplantation. Hepatology Forum. 2026;7(3):241-248. doi:10.14744/hf.2026.50793
BibTeX
@article{Kalluru2026,
author = {Kalluru, Pavan Kumar Reddy and Buhulaigah, Hassan Emad and Allikesam, Kishan Kumar and Kuchi, Deekshitha and Muqtadir, Abdul and Onteddu, Nirmal and Cherukuri, Apoorva and Allagadda, Teja and Kamakkagari, Madhusree and Rajali, Hossein},
title = {MELD 3.0: Exploring and expanding its utility beyond transplantation},
journal = {Hepatology Forum},
year = {2026},
volume = {7},
number = {3},
pages = {241--248},
doi = {10.14744/hf.2026.50793}
}
EUVIMED